Company: SWKH
Filing Date: 2025-03-20
Form Type: 10-K
Source: 0001628280-25-013989
Chunk: 195

Company: SWK Holdings Corp
Filing Date: 2025-03-20
Form: 10-K
Item: Item 8
Chunk 195
---
, and expected volatility. For the year ended December 31, 2024, the risk-free rate range weighted average was 4.4%, and had a median of 4.4%. For the year ended December 31, 2023, the risk-free rate range weighted average was 4.3%, and had a median of 3.8%. For the year ended December 31, 2024, the expected life range weighted average was 5.8 years, and had a median of 4.3 years. For the year ended December 31, 2023, the expected life range weighted average was 3.4 years, and had a median of 4.4 years. For the year ended December 31, 2024, the expected volatility range weighted average was 65.6%, and had a median of 104.3%. For the year ended December 31, 2023, the expected volatility range weighted average 124.6%, and median of 134.4%.As of December 31, 2024, the Company had three royalty investments, Best, Ideal, and Flowonix, that were deemed to be impaired based on reductions in carrying value. As of December 31, 2024, the Company had one term loan, BIOLASE, that was deemed to be impaired based on reductions in carrying value. As of December 31, 2023, the Company had one royalty, Best, that was deemed to be impaired based on reductions in carrying value. The following table presents these royalty and the loans measured at amortized cost using the effective interest method, which approximates fair value, on a nonrecurring basis (in thousands):Total  Carrying  Value in  Consolidated  Balance SheetsQuoted Prices  in Active  Markets for  Identical  Assets  or Liabilities  (Level 1)Significant  Other  Observable  Inputs  (Level 2)Significant  Unobservable  Inputs  (Level 3)December 31, 2024$14,830 $— $— $14,830 December 31, 2023$2,587 $— $— $2,587  There were no liabilities measured at fair value on a nonrecurring basis as of December 31, 2024 or 2023.The following information is provided to help readers gain an understanding of the relationship between amounts reported in the accompanying consolidated financial